Bernhard Svejda

2.0k citations

30 papers · 1.5k indexed · 1 hit paper · h-index 18

Impact in

Neurology top 2%
- Neuroblastoma Research and Treatments
Oncology top 2%
- Lung Cancer Research Studies
- Pancreatic and Hepatic Oncology Research
- Bone health and treatments

Papers in

Oncology 18
- Lung Cancer Research Studies 13
- Bone health and treatments 2
Epidemiology 19
- Neuroendocrine Tumor Research Advances 19

Co-authors: Mark Kidd Irvin M. Modlin Björn Gustafsson Ben Lawrence Anthony Chan Roswitha Pfragner Benjamin Lawrence Simon Schimmack
Journals: Cancer (4 papers)PLoS ONE (4 papers)Gastroenterology (3 papers)Endocrinology and Metabolism Clinics of North America (2 papers)Cancer Science (2 papers)
Partner nations: United States Austria Norway

In The Last Decade

Bernhard Svejda

29 papers receiving 1.5k citations

Hit Papers

align trajectories log scale

The Epidemiology of Gastroenteropancreatic Neuroendocrine Tumors 2011 · 632 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2011 Endocrinology and Metabolism Clinics of North America

Peers

Countries citing papers authored by Bernhard Svejda

Since Specialization

Citations

This map shows the geographic impact of Bernhard Svejda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernhard Svejda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernhard Svejda more than expected).

Fields of papers citing papers by Bernhard Svejda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernhard Svejda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernhard Svejda. The network helps show where Bernhard Svejda may publish in the future.

Co-authors

The 25 scholars most cited alongside Bernhard Svejda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Bernhard Svejda Line = papers co-authored together Bernhard Svejda links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Positionspapier zur medikamentenassoziierten Osteonekrose des Kiefers (MRONJ) Wiener Medizinische Wochenschrift ·Bernhard Svejda, С Н Стонис, Reinhard Gruber, B. Hounyo, Ernst Elke, R. Gasser, Gert Santler, Hans Peter Dimai	2016	38
2	Positionspapier zur medikamentenassoziierten Osteonekrose des Kiefers (MRONJ) Bernhard Svejda, С Н Стонис, Reinhard Gruber, B. Hounyo, Ernst Elke, R. Gasser, Gert Santler, Hans Peter Dimai	2015	2
3	Ursolic acid from Trailliaedoxa gracilis induces apoptosis in medullary thyroid carcinoma cells Molecular Medicine Reports ·Betty L. Jones, Bernhard Svejda, A. V. Kosyuk, Sonja Sturm, Hermann Stuppner, Elisabeth Ingolić, Harald Höger, Veronika Siegl, محمد الطاهر بنادى, A. Sadjak, Roswitha Pfragner	2015	9
4	Chromogranin A and Its Fragments as Regulators of Small Intestinal Neuroendocrine Neoplasm Proliferation PLoS ONE ·Francesco Giovinazzo, Simon Schimmack, Bernhard Svejda, Daniele Alaimo, Roswitha Pfragner, Irvin M. Modlin, Mark Kidd	2013	20
5	The Stimulatory Adenosine Receptor ADORA2B Regulates Serotonin (5-HT) Synthesis and Release in Oxygen-Depleted EC Cells in Inflammatory Bowel Disease PLoS ONE ·Lifan YU, Olesia SAVCHENKO, Bernhard Svejda, Daniele Alaimo, Øystein Brenna, Roswitha Pfragner, van Reisen, Mark Kidd	2013	17
6	Microencapsulation of small intestinal neuroendocrine neoplasm cells for tumor model studies Cancer Science ·Anne Mari Rokstad, Björn Gustafsson, Terje Espevik, Ingunn Bakke, Roswitha Pfragner, Bernhard Svejda, Irvin M. Modlin, Mark Kidd	2012	12
7	Comparison of PCR-based detection of chromogranin A mRNA with traditional histological lymph node staging of small intestinal neuroendocrine neoplasia BMC Research Notes ·Ben Lawrence, Barton Kenney, Bernhard Svejda, Simon Schimmack, Daniele Alaimo, Andrea Barbieri, Jaroslaw Jedrych, Mark Kidd, Irvin M. Modlin	2012	3
8	The clinical implications and biologic relevance of neurofilament expression in gastroenteropancreatic neuroendocrine neoplasms Cancer ·Simon Schimmack, Ben Lawrence, Bernhard Svejda, Daniele Alaimo, Hubertus Schmitz‐Winnenthal, Lars Fischer, Markus W. Büchler, Mark Kidd, Irvin M. Modlin	2011	16
9	The Clinical Relevance of Chromogranin A as a Biomarker for Gastroenteropancreatic Neuroendocrine Tumors Endocrinology and Metabolism Clinics of North America ·Ben Lawrence, Björn Gustafsson, Mark Kidd, (unknown), Bernhard Svejda, Irvin M. Modlin	2011	117
10	The Epidemiology of Gastroenteropancreatic Neuroendocrine Tumors Endocrinology and Metabolism Clinics of North America ·Ben Lawrence, Björn Gustafsson, Anthony Chan, Bernhard Svejda, Mark Kidd, Irvin M. Modlin Hit paper breakdown →	2011	632
11	A water soluble tri-cationic porphyrin–EDTA conjugate induces apoptosis in human neuroendocrine tumor cell lines Bioorganic Chemistry ·Gert Schwach, Patchanita Thamyongkit, Lorenz Michael Reith, Bernhard Svejda, Günther Knör, Roswitha Pfragner, Wolfgang Schoefberger	2011	13
12	Gene Network Inference and Biochemical Assessment Delineates GPCR Pathways and CREB Targets in Small Intestinal Neuroendocrine Neoplasia PLoS ONE ·Ignat Drozdov, Bernhard Svejda, Björn Gustafsson, Shrikant Mane, Roswitha Pfragner, Mark Kidd, Irvin M. Modlin	2011	25
13	Hypoxia and Gut Neuroendocrine Cells: The Role of HIF-1α, NfκB and Serotonin Production From Enterochromaffin Cells in Intestinal Ischemia Gastroenterology ·LJ Rachowicz, Bernhard Svejda, Roswitha Pfragner, Björn Gustafsson, Mark Kidd, Erik Solligård	2011	2
14	Limitations in small intestinal neuroendocrine tumor therapy by mTor kinase inhibition reflect growth factor–mediated PI3K feedback loop activation via ERK1/2 and AKT Cancer ·Bernhard Svejda, Mark Kidd, Martin L. West, Ben Lawrence, Roswitha Pfragner, Irvin M. Modlin	2011	68
15	The diversity and commonalities of gastroenteropancreatic neuroendocrine tumors Langenbeck s Archives of Surgery ·Simon Schimmack, Bernhard Svejda, Benjamin Lawrence, Mark Kidd, Irvin M. Modlin	2011	115
16	A Nomogram to Assess Small-Intestinal Neuroendocrine Tumor (‘Carcinoid’) Survival Neuroendocrinology ·Irvin M. Modlin, Björn Gustafsson, Marianne Pavel, Bernhard Svejda, Benjamin Lawrence, Mark Kidd	2010	72
17	The 5‐HT_2B receptor plays a key regulatory role in both neuroendocrine tumor cell proliferation and the modulation of the fibroblast component of the neoplastic microenvironment Cancer ·Bernhard Svejda, Mark Kidd, Francesco Giovinazzo, Karim M. Eltawil, Björn Gustafsson, Roswitha Pfragner, Irvin M. Modlin	2010	53
18	A Clinical Perspective on Gastric Neuroendocrine Neoplasia Current Gastroenterology Reports ·Ben Lawrence, Mark Kidd, Bernhard Svejda, Irvin M. Modlin	2010	26
19	Autoregulatory effects of serotonin on proliferation and signaling pathways in lung and small intestine neuroendocrine tumor cell lines Cancer ·Ignat Drozdov, Mark Kidd, Björn Gustafsson, Bernhard Svejda, Richard A. Joseph, Roswitha Pfragner, Irvin M. Modlin	2009	46
20	Asymmetrically substituted cationic indole- and fluorene porphyrins inhibit tumor proliferation in small intestinal neuroendocrine tumors and medullary thyroid carcinomas European Journal of Medicinal Chemistry ·Dongming Yan, Jochen Stutz, Bernhard Svejda, Lorenz Michael Reith, 直規中安, Roswitha Pfragner, Wolfgang Schoefberger	2009	17

About Bernhard Svejda

Bernhard Svejda is a scholar working on Oncology, Epidemiology, Gastroenterology, Neurology and Biochemistry, having authored 30 papers that have together received 1.5k indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (19 papers), Lung Cancer Research Studies (13 papers), Neuroblastoma Research and Treatments (6 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), Pancreatic function and diabetes (3 papers), Bone health and treatments (2 papers), Cancer Mechanisms and Therapy (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). The work is most often cited by research in Neurology (652 citations), Oncology (1.1k citations), Epidemiology (1.1k citations), Gastroenterology (123 citations) and Physiology (22 citations). Bernhard Svejda has collaborated with scholars based in United States, Austria and Norway. Frequent co-authors include Mark Kidd, Irvin M. Modlin, Björn Gustafsson, Ben Lawrence, Anthony Chan, Roswitha Pfragner, Benjamin Lawrence, Simon Schimmack, Marianne Pavel and Francesco Giovinazzo. Their work appears in journals such as Cancer, PLoS ONE, Gastroenterology, Endocrinology and Metabolism Clinics of North America and Cancer Science.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact